A Series A funding round totaling $11.0M has been secured by Clara Health, the clinical research firm that recently announced its acquisition by M&B Sciences.
The capital infusion arrives as Clara Health integrates with its new strategic and mission-aligned partner, M&B Sciences. The companies have expressed a strong belief that this merger will enable them to make a greater difference in how patients experience clinical trials and contribute to breakthrough research.
.png&w=3840&q=75)
















